Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
283
-
Total 13F shares, excl. options
-
108M
-
Shares change
-
+2.54M
-
Total reported value, excl. options
-
$1.97B
-
Value change
-
+$47.7M
-
Put/Call ratio
-
1.19
-
Number of buys
-
107
-
Number of sells
-
-131
-
Price
-
$18.20
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2020
352 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2020.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 283 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 108M shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (15.3M shares), PAULSON & CO. INC. (11.3M shares), ARK Investment Management LLC (8.62M shares), Adelphi Capital LLP (7.58M shares), RENAISSANCE TECHNOLOGIES LLC (5.58M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.36M shares), NORTHERN TRUST CORP (4.38M shares), MACQUARIE GROUP LTD (4.26M shares), Parametric Portfolio Associates LLC (3.52M shares), and Mondrian Investment Partners LTD (3.27M shares).
This table shows the top 283 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.